Plasma metabolomic profiles in different stages of CKD. - Wikidata - wikimedia - TriplyDB

Plasma metabolomic profiles in different stages of CKD.

Plasma metabolomic profiles in different stages of CKD.

http://www.wikidata.org/entity/Q36652795

about

Integrated genomics and metabolomics in nephrology Assessment of metabolomic and proteomic biomarkers in detection and prognosis of progression of renal function in chronic kidney disease Application of metabolomics: Focus on the quantification of organic acids in healthy adults Serum metabolomic profiling and incident CKD among African Americans Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus.Optimized metabolomic approach to identify uremic solutes in plasma of stage 3-4 chronic kidney disease patients.Metabolomics of renal venous plasma from individuals with unilateral renal artery stenosis and essential hypertension Metabolomics and renal disease.Effect of dietary sodium restriction on human urinary metabolomic profiles.Uraemic toxins and new methods to control their accumulation: game changers for the concept of dialysis adequacy Identification of biomarkers for development of end-stage kidney disease in chronic kidney disease by metabolomic profiling A combined epidemiologic and metabolomic approach improves CKD prediction.New methods and technologies for measuring uremic toxins and quantifying dialysis adequacy.Biomarkers in diabetic nephropathy: Present and future.Metabonomic biomarkers for risk factors of chronic kidney disease.Metabolomics for clinical use and research in chronic kidney disease.An overview of renal metabolomics.The role of cGMP and its signaling pathways in kidney disease.Metabolic profiling of human plasma and urine in chronic kidney disease by hydrophilic interaction liquid chromatography coupled with time-of-flight mass spectrometry: a pilot study.Plasma metabolomics profiling of maintenance hemodialysis based on capillary electrophoresis - time of flight mass spectrometry.Metabolomic Profiling of Arginine Metabolome Links Altered Methylation to Chronic Kidney Disease Accelerated Atherosclerosis.Metabolite markers of incident CKD risk Metabolomics and Gene Expression Analysis Reveal Down-regulation of the Citric Acid (TCA) Cycle in Non-diabetic CKD Patients.Inhibiting aerobic glycolysis suppresses renal interstitial fibroblast activation and renal fibrosis.Associations of Plasma Amino Acid and Acylcarnitine Profiles with Incident Reduced Glomerular Filtration Rate.A Systems-Level View of Renal Metabolomics.Association Between Newborn Metabolic Profiles and Pediatric Kidney Disease.

P2860

Q26823928-329032A5-9E56-41A1-9164-F0679230BB59 Q33591146-82224040-2CA2-4808-A06B-1FFE6A52FDB8 Q33783924-9F95A685-BBD8-4B4F-B686-7E1C47BB2AFC Q34008968-F1E8A493-17AC-45E0-8CED-28C222387C72 Q34411671-A3B1EF23-72AD-4B0C-A106-4018BF1A0497 Q34926535-1AFDE1C9-37B2-45D6-960F-729942436093 Q35161725-8CF20DA8-A241-49EC-9DB5-E588EF53B22F Q35778649-BC2C2161-F551-43A8-B184-0F9F59D2AA6F Q35817074-C716DFD2-33FE-4E98-84A4-0818557E8F10 Q35891553-B62307BC-D460-4403-A762-3D30824CD056 Q36910790-72FAB9D8-B0E4-44B5-A252-6F8B7750FD15 Q37078386-2F747DA1-68D2-4D1E-A25B-0C07F89E3D75 Q38274050-B48B2A86-473A-49AC-8964-9D42C7172295 Q38290083-0C8DE3E0-2959-4AC6-ABDD-638AEDC091A8 Q38741939-0DE158C2-C798-4C77-B92F-A2DBCD21C5C9 Q38750287-0DC5B60C-8CB2-420F-9484-F7D1035428E1 Q38815775-E2CE223A-03D9-4A43-9CC2-81C21FDB6918 Q38896087-16E8BF86-69D8-4F68-B526-A8723731EC99 Q39023043-DA170263-03FC-4E29-9F6B-D551459FA52D Q41420103-BB35F79E-9F73-4A66-B575-089D7FB87B59 Q41979223-9ED941EF-5A1B-45F5-996C-3F42AA19299E Q42772434-0E01059B-E558-43DA-B827-2DEA9EC42225 Q46673943-B1081F70-F506-4CCE-A5D9-8D8D28530456 Q48823999-FD6BE5F8-0E14-4102-8740-F1AE2091693B Q51412140-27491F9F-F7A0-4E06-9306-79601DE0B4E3 Q52336692-DF844387-166E-4D5C-A028-19233EA4AE58 Q55092989-F9155A50-96D0-4E37-BB89-C5098FE41F73

P2860

Plasma metabolomic profiles in different stages of CKD.

http://www.wikidata.org/entity/Q36652795

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Plasma metabolomic profiles in different stages of CKD.

@ast

Plasma metabolomic profiles in different stages of CKD.

@en

type

label

Plasma metabolomic profiles in different stages of CKD.

@ast

Plasma metabolomic profiles in different stages of CKD.

@en

prefLabel

Plasma metabolomic profiles in different stages of CKD.

@ast

Plasma metabolomic profiles in different stages of CKD.

@en

P1433

Q36652795-C9973DD7-99F2-4629-BB4D-7E46E91E4EEA

P1476

Q36652795-EEE36156-C8B8-48D3-8A55-2B596C356E97

P2093

Q36652795-57E46A82-AB4E-45DE-830B-D8DDBF14253A

Q36652795-5C4D5910-DD95-429F-8D5C-77818961107E

Q36652795-6D93C82A-3551-4A01-B223-859341A1C108

Q36652795-6E950F54-0721-46C0-B4CD-9EB3B4EA1B9B

Q36652795-A03FA987-1F13-44E7-8F34-8BF093625ACE

Q36652795-A4D35705-330B-4E8A-9713-45A71624F62F

P2860

Q36652795-1382A1EA-870B-4F6F-9D93-060E7F21A338

Q36652795-14315BFA-AE2F-4BB6-863A-111EA10B044A

Q36652795-1F073A57-6DEF-455B-AE18-57454818F2F5

Q36652795-210769D8-902C-406C-B650-3E036F40DD07

Q36652795-2D143590-8728-4A15-B468-B44F3E2841F8

Q36652795-2DB4600E-74D2-4FFC-B927-CEBF51F86E53

Q36652795-320EA547-DD2D-487A-AECC-5FC622F2065E

Q36652795-47422D33-E71D-4DB7-9EBB-30F18D5AAB47

Q36652795-4A2F6388-EEFF-47D5-A131-84E8CA6EF915

Q36652795-4AB8F0D3-2CF4-413A-94BF-79335DEB38DA

P304

Q36652795-65005335-2468-4B97-B5B3-3F030EBA1733

P31

Q36652795-C6401B59-F500-4199-BBED-C10CF3692109

P356

Q36652795-FA52EE4F-A1BE-4717-8CB2-73EC2B5A2807

P433

Q36652795-2EF2319D-E9D7-418C-BC15-007B2F14E88B

P478

Q36652795-416B46E3-ADBA-40D2-AF6E-EECDB82252FA

P577

Q36652795-FD1DE5D4-2FDF-4B4B-AFEA-C60766FF5E5E

P698

Q36652795-5CAF5BAF-A4E6-42AD-97D0-CBA2304347D8

P932

Q36652795-3078F777-7137-4822-9DE1-8972EE27F4AC

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Plasma metabolomic profiles in different stages of CKD.

@en

P2093

David L Vander Jagt

http://www.w3.org/2001/XMLSchema#string

Elizabeth Kensicki

http://www.w3.org/2001/XMLSchema#string

Harold I Feldman

http://www.w3.org/2001/XMLSchema#string

Kirk L Pappan

http://www.w3.org/2001/XMLSchema#string

Raymond R Townsend

http://www.w3.org/2001/XMLSchema#string

Vallabh O Shah

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

The L-arginine-nitric oxide pathway

Statistical significance for genomewide studies

Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables

Organization of GC/MS and LC/MS metabolomics data into chemical libraries

Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

Structural specificity of substrate for S-adenosylmethionine:protein arginine N-methyltransferases

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems.

P304

363-370

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.05540512

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23220422

http://www.w3.org/2001/XMLSchema#string

P932

3586968

http://www.w3.org/2001/XMLSchema#string